E whakaatuhia ana ngā hua e 1 - 20 o te 20 Whakamahine hua
  1. 1
  2. 2
    ā- Plank, M. J. (Michael J.)
    I whakaputaina 2004
    Ngā marau
    Pukapuka
  3. 3
  4. 4
  5. 5
  6. 6
    ā- Garden, Kathryn L. (Kathryn Lee)
    I whakaputaina 1981
    Ngā marau ...Atherosclerosis Diagnosis....
    Tuhinga Whakapae Pukapuka
  7. 7
  8. 8
  9. 9
    ā- Mol, Annemarie
    I whakaputaina 2002
    Ngā marau ...Atherosclerosis Netherlands....
    Pukapuka
  10. 10
  11. 11
    I whakaputaina 2007
    Rārangi ihirangi
    Pukapuka
  12. 12
    I whakaputaina 2007
    Rārangi ihirangi
    Pukapuka
  13. 13
    I whakaputaina 2004
    Rārangi ihirangi ...Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? ...
    Pukapuka
  14. 14
    I whakaputaina 2008
    Rārangi ihirangi ...Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study /...
    Pukapuka
  15. 15
    I whakaputaina 2002
    Rārangi ihirangi ...Psychosocial Factors, Sex Differences, and Atherosclerosis: Lessons from Animal Models /...
    Pukapuka
  16. 16
    I whakaputaina 2003
    Rārangi ihirangi ...The Cell Biology of Atherosclerosis, Heart Attacks, and Strokes --...
    Pukapuka
  17. 17
    I whakaputaina 1979
    Pukapuka
  18. 18
    ā- Labarthe, Darwin
    I whakaputaina 2011
    Rārangi ihirangi ...Cardiovascular diseases : a global public health challenge -- Distributions and disparities -- Atherosclerosis -- Coronary heart disease -- Stroke -- Related conditions -- Genes and environment -- Dietary imbalance -- Physical inactivity -- Obesity -- Adverse blood lipid profile -- High blood pressure -- Diabetes and the metabolic syndrome -- Smoking and other tobacco use -- Other personal factors -- Social and physical environment -- What causes cardiovascular diseases? ...
    Pukapuka
  19. 19
    I whakaputaina 2011
    Rārangi ihirangi ...Overview -- Acute effects of particulate matter on the risk of myocardial infarction -- Chronic effects of air pollution on cardiovascular health -- Particle characterization -- Exposure assessment for ambient ultrafine particles -- From exposure to dose -- Translocation of inhaled nanoparticles -- Role of chemical composition in determining the cardiovascular effects of particles -- In vitro studies -- Experimental studies in animals -- Human exposure studies -- Panel studies -- Particulates and oxidative stress -- Role of inflammation in the atherogenic effects of particulate matter -- Inhaled particles, postprandial lipids, and their possible contribution to atherogenesis : the Trojan horse hypothesis -- Inhaled particulate matter and atherosclerosis in humans -- Effects of nanoparticulates on the pulmonary vasculature -- Particulate matter, hypertension, and the metabolic syndrome -- Particles and the vascular endothelium -- Particles, coagulation, and thrombosis -- Particles and the pathogenesis of atherothrombosis -- Particles and the autonomic nervous system -- Air pollution and cardiac arrhythmia -- Risk assessment -- Environmental regulation of particulate matter -- From ambient ultrafine particles to nanotechnology and nanotoxicology....
    Pukapuka
  20. 20
    I whakaputaina 2010
    Rārangi ihirangi ...Ocular inflammation models Karsten Gronert; 32. Atherosclerosis in experimental animal models Aksam Merched and Lawrence Chan; 33. ...
    Pukapuka